Study guide
9.1 2018 Periodontal Staging, Grading & Risk Factor Assessment
Australian Dental Council ADC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Examination Overview
1.1 ADC Written Examination Structure, Scoring Clusters & Australian Practice Context 1.2 Clinical Scenario Reasoning & Australian Therapeutic Guidelines Alignment
2 Chapter 2: Restorative Dentistry & Fixed Prosthodontics
2.1 Minimal Intervention Dentistry, Caries Risk & Lesion Management 2.2 Direct Restorative Materials, Resin Composites & Dental Amalgam 2.3 Indirect Restorations, Crown Preparation, Veneers & Onlays 2.4 Dental Adhesion, Etch-and-Rinse vs Self-Etch Systems & Hybrid Layer 2.5 Diagnosis & Management of Tooth Wear (Erosion, Attrition, Abrasion, Abfraction)
3 Chapter 3: Dental Pharmacology & Therapeutic Guidelines
3.1 Local Anaesthetic Agents, Vasoconstrictors & Injection Techniques 3.2 Dental Analgesia Protocols, NSAIDs, Paracetamol & Opioid Stewardship 3.3 Dental Antibiotic Prescribing, Prophylaxis & Therapeutic Guidelines 3.4 Management of Patients on Anticoagulants & Antiplatelet Therapy 3.5 Medication-Related Osteonecrosis of the Jaw (MRONJ) Risk & Management
4 Chapter 4: General Medicine & Medically Compromised Patients
4.1 Dental Office Medical Emergencies, Anaphylaxis & Resuscitation Protocols 4.2 Management of Patients with Cardiovascular, Respiratory & Renal Diseases 4.3 Special Needs Dentistry, Geriatric Care & Dental Management in Pregnancy 4.4 Infective Endocarditis Prophylaxis & Cardiac Risk Assessment
5 Chapter 5: Oral Medicine & Oral Pathology
5.1 Ulcerative, Vesiculobullous & Immune-Mediated Oral Mucosal Diseases 5.2 Oral Potentially Malignant Disorders (OPMDs) & Oral Cancer Screening 5.3 Salivary Gland Disorders, Sialadenitis & Cysts of the Jaws 5.4 Oral Biopsy Indications, Diagnostic Pathways & Specialist Referral
6 Chapter 6: Endodontics
6.1 Pulpal and Periapical Diagnostic Classification & Diagnostic Testing 6.2 Canal Instrumentation, Working Length & Irrigation Protocols 6.3 Root Canal Obturation, Endodontic Retreatment & Failure Analysis 6.4 Endodontic Management of Traumatic Dental Injuries & Vital Pulp Therapy
7 Chapter 7: Oral Surgery
7.1 Surgical & Simple Exodontia Techniques & Intraoperative Complications 7.2 Assessment & Surgical Management of Impacted Third Molars 7.3 Oroantral Communication, Displacement & Trigeminal Nerve Injury Prevention 7.4 Management of Spreading Odontogenic Infections & Fascial Space Abscesses
8 Chapter 8: Paediatric Dentistry & Orthodontics
8.1 Primary Tooth Pulpotomy, Pulpectomy & Stainless Steel Crown Restoration 8.2 Early Childhood Caries, Space Maintenance & Traumatic Primary Dentition 8.3 Malocclusion Classification, Etiology & Interceptive Orthodontic Management 8.4 Non-Pharmacological Behaviour Guidance, Child Protection & Consent
9 Chapter 9: Periodontics
9.1 2018 Periodontal Staging, Grading & Risk Factor Assessment 9.2 Subgingival Debridement, Plaque Control & Antimicrobial Adjuncts 9.3 Periodontal Surgical Flaps, Regenerative Therapy & Furcation Management 9.4 Supportive Periodontal Care, Maintenance Protocols & Risk Re-evaluation
10 Chapter 10: Preventive Dentistry
10.1 Caries Risk Assessment Models (CAMBRA) & Personalised Prevention 10.2 Fluoride Mechanisms, Topical Applications & Community Fluoridation 10.3 Dietary Counselling, Stephan Curve Dynamics & Erosion Prevention 10.4 Pit and Fissure Sealants, Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)
11 Chapter 11: Dental Emergencies
11.1 Emergency Management of Severe Odontogenic Pain & Acute Irreversible Pulpitis 11.2 Acute Management of Avulsed, Luxated & Fractured Permanent Teeth 11.3 Diagnosis, Differentiation & Treatment of Cracked Tooth Syndrome 11.4 Emergency Management of Post-Extraction Hemorrhage & Acute Abscesses
12 Chapter 12: Pain & Behaviour Management
12.1 Assessment & Management of Dental Anxiety, Phobia & Dental Fear 12.2 Nitrous Oxide Inhalation Sedation & Intravenous Sedation Guidelines 12.3 Diagnosis & Management of Temporomandibular Disorders & Chronic Facial Pain 12.4 Informed Consent, Patient Autonomy, Ethics & Professional Boundaries
13 Chapter 13: Removable Prosthodontics
13.1 Complete Denture Design, Impression Techniques & Maxillomandibular Relations 13.2 Removable Partial Denture Design, Surveying, Clasping & RPI System 13.3 Post-Insertion Problems, Sore Spots, Relining & Rebase Procedures 13.4 Denture Stomatitis, Tissue Conditioning & Pre-Prosthetic Surgery
14 Chapter 14: Dental Radiography & Imaging
14.1 Radiation Physics, ALARA Principles, Shielding & Dose Reduction 14.2 Intraoral Radiographic Techniques, Positioning & Geometry 14.3 Radiographic Interpretation, Normal Anatomical Landmarks & Artifacts
15 Chapter 15: Infection Prevention & Control
15.1 Standard & Transmission-Based Precautions in Dental Practice 15.2 Instrument Reprocessing, Autoclaving & Sterilisation Monitoring 15.3 Dental Unit Waterlines, Waste Management & Occupational Exposure Protocols
16 Chapter 16: Dental Implants & Peri-Implant Diseases
16.1 Patient Selection, Bone Density, Anatomic Constraints & Prosthetic Planning 16.2 Peri-Implant Anatomy, Hygiene Protocols & Maintenance Monitoring 16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases
9.1 2018 Periodontal Staging, Grading & Risk Factor Assessment
Key Takeaways Explain This Topic AI
The 2018 AAP/EFP World Workshop Classification categorises periodontitis by Stage (I-IV, reflecting disease severity and complexity) and Grade (A-C, reflecting rate of progression and risk modifiers).
Periodontitis Staging is determined primarily by interdental clinical attachment loss (CAL) at the site of greatest loss, radiographic bone loss (RBL), and tooth loss due to periodontitis.
Periodontitis Grading utilizes indirect evidence (% bone loss / age ratio) and is modified by key systemic risk factors: smoking status (<10 vs ≥10 cigarettes/day) and diabetes status (HbA1c <7.0% vs ≥7.0%).
Basic Periodontal Examination (BPE) or PSR screening guides clinical management in Australian practice, mandating full-mouth periodontal charting when BPE Code 3 or 4 is recorded.
Drug-induced gingival overgrowth is caused by calcium channel blockers (e.g., Nifedipine), anticonvulsants (Phenytoin), and immunosuppressants (Cyclosporine), requiring biofilm control and medical substitution.
Last updated: August 2026
9.1 2018 Periodontal Staging, Grading & Risk Factor Assessment
Accurate diagnosis, staging, and grading of periodontal and peri-implant conditions form the cornerstone of evidence-based periodontics in contemporary Australian dental practice. Adopted worldwide following the 2018 AAP/EFP World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions , this diagnostic framework is fully endorsed by the Australian Society of Periodontology (ASP) and tested extensively in the Australian Dental Council (ADC) Written Examination .
1. Diagnostic Categorisation: Health, Gingivitis & Periodontitis
The 2018 classification establishes clear physiological and pathological boundaries between periodontal health, plaque-induced gingivitis, and periodontitis, accounting for both intact and reduced periodontium clinical presentations.
Diagnostic Category Periodontal Status Probing Depths (PD) Bleeding on Probing (BOP) Clinical Attachment Loss (CAL) & Bone Loss
Periodontal Health Intact Periodontium PD ≤ 3 mm BOP < 10% of sites No CAL or Radiographic Bone Loss (RBL)
Periodontal Health Reduced Periodontium (Non-Periodontitis) PD ≤ 3 mm BOP < 10% of sites CAL present (e.g. recession, crown lengthening); no RBL
Periodontal Health Reduced Periodontium (Stable Periodontitis) PD ≤ 4 mm (no 4 mm site with BOP) BOP < 10% of sites CAL & RBL present; disease successfully treated and stable
Plaque-Induced Gingivitis Intact Periodontium PD ≤ 3 mm BOP ≥ 10% of sites No CAL or RBL
Plaque-Induced Gingivitis Reduced Periodontium (Non-Periodontitis or Stable) PD ≤ 3 mm BOP ≥ 10% of sites Pre-existing CAL present; no active attachment loss
Periodontitis Periodontal Breakdown Pockets ≥ 4 mm with BOP or CAL BOP variable Interdental CAL detectable at ≥2 non-adjacent teeth, or buccal/lingual CAL ≥3 mm with pockets >3 mm at ≥2 teeth
2. 2018 Periodontitis Staging Framework (Severity & Complexity)
Staging reflects the severity of clinical attachment loss and bone destruction at presentation, as well as the complexity of clinical management. Staging is assigned based on the site of greatest destruction across the dentition.
A. Severity Matrix by Stage
Stage I (Initial Periodontitis):
Interdental CAL (site of greatest loss): 1 to 2 mm.
Radiographic Bone Loss (RBL): Coronal third (<15% of root length).
Tooth Loss due to Periodontitis: 0 teeth.
Stage II (Moderate Periodontitis):
Interdental CAL: 3 to 4 mm.
RBL: Coronal third (15% to 33% of root length).
Tooth Loss due to Periodontitis: 0 teeth.
Stage III (Severe Periodontitis with Potential for Additional Tooth Loss):
Interdental CAL: ≥ 5 mm.
RBL: Extending to middle or apical third of root (>33%).
Tooth Loss due to Periodontitis: ≤ 4 teeth lost.
Stage IV (Advanced Periodontitis with Extensive Tooth Loss & Potential for Dentition Collapse):
Interdental CAL: ≥ 5 mm.
RBL: Extending to middle or apical third of root (>33%).
Tooth Loss due to Periodontitis: ≥ 5 teeth lost.
B. Complexity Factors
Stage I: Maximum probing depth ≤ 4 mm; horizontal bone loss predominant.
Stage II: Maximum probing depth ≤ 5 mm; horizontal bone loss predominant.
Stage III: Probing depths ≥ 6 mm; vertical bone loss ≥ 3 mm; furcation involvement Class II or III; moderate alveolar ridge defect.
Stage IV: In addition to Stage III criteria: masticatory dysfunction, secondary occlusal trauma (tooth hypermobility Grade 2 or 3), severe ridge defect, bite collapse, drifting/flaring of teeth, and fewer than 20 residual teeth (fewer than 10 opposing pairs).
3. 2018 Periodontitis Grading Framework (Rate of Progression & Risk Modifiers)
Grading indicates the biologic rate of disease progression , responsiveness to standard therapy, and potential impact on systemic health. A patient is initially assigned Grade B by default and modified up or down based on direct/indirect evidence and risk factors.
Grading Criteria Grade A: Slow Rate Grade B: Moderate Rate Grade C: Rapid Rate
Direct Evidence No loss of CAL or RBL over 5 years < 2 mm CAL or RBL loss over 5 years ≥ 2 mm CAL or RBL loss over 5 years
Indirect Evidence (% RBL / Age) Ratio < 0.25 Ratio 0.25 to 1.0 Ratio > 1.0
Case Phenotype Heavy biofilm deposits with low levels of destruction Destruction commensurate with biofilm deposits Destruction exceeds expectations given biofilm; early-onset pattern
- Grade Modifier: Smoking Non-smoker Smoker < 10 cigarettes / day Smoker ≥ 10 cigarettes / day
- Grade Modifier: Diabetes Normoglycaemic / No diabetes Diabeteic with HbA1c < 7.0% Diabetic with HbA1c ≥ 7.0%
Note on ADC Examination Rules: If a patient has multiple grade modifiers (e.g. non-smoker but HbA1c is 8.2%), the highest severity modifier dictates the final grade (Grade C).
4. Screening Protocols: BPE & PSR in Australian Practice
In Australian clinical practice, the Basic Periodontal Examination (BPE) (or Periodontal Screening and Recording - PSR) is a rapid screening tool performed on all new patients and regular check-ups using a WHO dentate probe (featuring a 0.5 mm ball tip and a black band between 3.5 mm and 5.5 mm). BPE / PSR Scoring Codes & Required Clinical Actions:
Code 0: Black band completely visible; no BOP; no calculus/overhangs.
Action: Routine preventive care; re-screen at recall.
Code 1: Black band completely visible; BOP present; no calculus/overhangs.
Action: Oral hygiene instruction (OHI); supragingival plaque control.
Code 2: Black band completely visible; supragingival/subgingival calculus or overhangs present.
Action: OHI; removal of calculus and restoration overhangs.
Code 3: Black band partially obscured by gingival margin (Probing depth 3.5 mm to 5.5 mm).
Action: Detailed periodontal charting of the affected sextant; Step 1 & 2 therapy.
Code 4: Black band completely disappears into pocket (Probing depth > 5.5 mm).
Action: Full-mouth detailed periodontal charting; comprehensive Step 1 & 2 therapy +/- specialist referral.
Code *: Furcation involvement (Class I-IV), tooth mobility Grade 2-3, or recession >3.5 mm.
Action: Detailed recording of specific defect regardless of depth code.
5. Systemic Risk Factors & Drug-Induced Gingival Overgrowth
Systemic factors significantly influence periodontal pathogenesis, immune response, and treatment prognosis.
A. Major Systemic Risk Factors
Smoking: Primary environmental risk factor. Induces peripheral vasoconstriction (masking clinical signs of inflammation like BOP), impairs neutrophil chemotaxis and phagocytosis, suppresses IgG antibody production, and increases prevalence of Porphyromonas gingivalis and Tannerella forsythia .
Diabetes Mellitus: Bidirectional relationship. Uncontrolled hyperglycaemia leads to accumulation of Advanced Glycation End-products (AGEs) , which interact with RAGE receptors on monocytes and endothelial cells, hyper-amplifying pro-inflammatory cytokine release (IL-1β, TNF-α, IL-6) and accelerating alveolar bone resorption.
B. Drug-Induced Gingival Overgrowth (DIGO)
Three major pharmacological classes cause gingival enlargement, typically originating at the interdental papillae within 1 to 3 months of drug initiation:
Anticonvulsants: Phenytoin (prevalence ~50%). Fibroblastic hyperplasia with dense collagen accumulation.
Immunosuppressants: Cyclosporine (prevalence ~30%). Highly vascular enlargement; exacerbated by concomitant calcium channel blocker use.
Calcium Channel Blockers (CCBs): Nifedipine , Amlodipine , Diltiazem, Verapamil (prevalence ~10-20%).
Management in Dental Practice: Rigorous professional and self-performed plaque control; surgical gingivectomy if functional/aesthetic impairment occurs; medical consultation with the patient's physician to consider drug substitution (e.g., swapping Nifedipine to an ACE inhibitor or Tacrolimus instead of Cyclosporine).